Recombinant antigens
p30 (SAG1)
for Toxoplasma gondii
Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. It has been described in the literature that this 30 kDa protein has the capacity to carry out the serological analysis of Toxoplasma infections.
- NAME
- P30 (sag1)
- DESCRIPTION
- Major surface antigen
- GEN
- SAG1
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen p30 (SAG1)
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Recombinant proteins for in vitro diagnosis of animal infectious diseases
- Bloqueador de inmunoensayo para proteínas hechas en <em>pichia pastoris</em>
- IVD reagents for TORCH
Videos
- How to reconsitute lyophizated vials
- IVD reagents for diagnosis of Toxoplasmosis
- How to use the inmunoassay blocker for anti-cross-reactive carbohydrate determinants (CCD) antibodies
Evaluaciones
- SAG1 (p30) from Toxoplasma gondii requires maintain its native conformation to detect IgM antibodies
Related proteins
Related antibodies
Reagent sheet
- NAME
- p30 (SAG1)
- DESCRIPTION
- Major surface antigen
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
